Project Grant HT94252510897
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...
- This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $669,421.00 to the University of Texas Health Science Center at Houston (UTHealth) to conduct research on the long-term impact of deployment exposures on neuropathy of brainstem pathways, associated symptoms, and health measures in veterans with Gulf War Illness. The research will be performed over a two-year period from September 30, 2024 to...
- The federal Project Grant award titled "FUNCTIONAL OUTCOMES AND BIOMARKERS IN OCCUPATIONAL BLAST EXPOSURE (FOB: OBE): THE IMPACT ON SERVICE MEMBERS, VETERANS, AND THEIR FAMILIES" is funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This $1,051,179 grant, awarded on September 15, 2025, supports research conducted by the Western Institute For Veterans Research (WIVR), a non-profit organization based in Salt Lake City, Utah. The...
- The University of Texas Health Science Center at Houston (UTHealth) received a $3,845,822 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to conduct a comparative effectiveness study on transdiagnostic behavior therapy versus treatment-as-usual for adjustment disorder following traumatic event exposure. The award runs from July 1, 2024 to June 30, 2028. The federal grant supports innovative biomedical research initiatives aimed at...
- The University of Texas Health Science Center at Houston (UTHealth) was awarded a $1,559,997 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports a pharmacology and efficacy study of a novel, blood-brain barrier (BBB)-permeable agent for the treatment of breast cancer brain metastases. The project will be conducted over a 3-year period from September 1, 2024 to August 31, 2027. The Military...
- The University of Texas Health Science Center at Houston was awarded a $1,498,514 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program. The grant will fund research from September 2022 through September 2026 to improve functional performance in transfemoral amputees through somatosensory augmentation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
- The University of Texas Health Science Center at Houston (UTHealth) was awarded a $769,578 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ENHANCING BIOENERGETICS AS A STRATEGY TO IMPROVE OUTCOME AFTER MILD TRAUMATIC BRAIN INJURY". The award, which runs from May 1, 2024 to April 30, 2027, will support UTHealth's efforts to advance scientific knowledge and develop innovative treatments for...
- This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
- The University of Texas Health Science Center at Houston (UTHealth) received a $777,586 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from September 30, 2024 to September 29, 2027, will fund the "Stress Inoculation Training (SIT): An Evidence-Driven, Military-Aligned Psychological Performance and Health Sustainment Prototype" research project. The project...
- The University of Texas Health Science Center at Houston received a $2,346,267.00 Project Grant award on July 1, 2025 from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The award will support a 4-year research project titled "Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced Entirely Remote 2-Week Integrated Treatment for Pain and PTSD". The research aims to develop and assess an integrated...
The University of Texas Health Science Center at Houston received a $950,743 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding will support the "FUNCTIONAL OUTCOMES AND BIOMARKERS IN OCCUPATIONAL BLAST EXPOSURE (FOB: OBE): THE IMPACT ON SERVICE MEMBERS, VETERANS, AND THEIR FAMILIES" research project over a performance period from September 15, 2025 to September 14, 2029. The project aims to transform healthcare for military service members, veterans, and the public by conducting advanced biomedical research on the functional outcomes and biomarkers related to occupational blast exposure. The research will focus on addressing critical health challenges relevant to the military and civilian populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $950.7k | 8/15/25 |